Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HBeAg Positive Chronic Hepatitis B Infection”

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT01456312
What this trial is testing

HBsAg Related Response Guided Therapy

Who this might be right for
Hepatitis B, Chronic
Gangnam Severance Hospital 200
Post-approval studies (Phase 4)UnknownNCT02894918
What this trial is testing

Evaluate Addition of Peginterferon Alfa-2a to Chronic Hepatitis B (CHB) Patients Treated With NAs

Who this might be right for
Chronic Hepatitis B
Henan Provincial People's Hospital 114
Post-approval studies (Phase 4)Study completedNCT00651209
What this trial is testing

A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B, Chronic
Novartis Pharmaceuticals 105
Not applicableStudy completedNCT01623778
What this trial is testing

Optimization of Antiviral Therapy of Chronic HBV Infection

Who this might be right for
Australia Antigen PositiveHepatitis BAdverse Effects
Changhai Hospital 67
Large-scale testing (Phase 3)Study completedNCT01519960
What this trial is testing

Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 165
Testing effectiveness (Phase 2)Study completedNCT01143662
What this trial is testing

Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Xiamen Amoytop Biotech Co., Ltd. 205
Not applicableStudy completedNCT01734018
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 50
Post-approval studies (Phase 4)Study completedNCT00940485
What this trial is testing

Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 200
Not applicableStudy completedNCT01667432
What this trial is testing

An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 141
Early research (Phase 1)Study completedNCT03714152
What this trial is testing

ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Assembly Biosciences 80
Post-approval studies (Phase 4)Study completedNCT03258710
What this trial is testing

Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 75
Testing effectiveness (Phase 2)Study completedNCT00869778
What this trial is testing

Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Chongqing Jiachen Biotechnology Ltd. 360
Testing effectiveness (Phase 2)WithdrawnNCT03125213
What this trial is testing

A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects

Who this might be right for
Hepatitis B, Chronic
Alios Biopharma Inc.
Post-approval studies (Phase 4)Study completedNCT01928511
What this trial is testing

Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy

Who this might be right for
Chronic Hepatitis B
Seng Gee Lim 254
Large-scale testing (Phase 3)Study completedNCT00116805
What this trial is testing

Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Gilead Sciences 266
Post-approval studies (Phase 4)UnknownNCT02973646
What this trial is testing

Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection

Who this might be right for
Chronic Hepatitis b
Third Affiliated Hospital, Sun Yat-Sen University 100
Large-scale testing (Phase 3)UnknownNCT01220596
What this trial is testing

Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hanyang University 228
Post-approval studies (Phase 4)WithdrawnNCT01727271
What this trial is testing

Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)

Who this might be right for
Hepatitis B
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT03903796
What this trial is testing

Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic HBV Infection
Jiangsu Hansoh Pharmaceutical Co., Ltd. 963
Post-approval studies (Phase 4)Study completedNCT02598063
What this trial is testing

Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 255
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation